CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Phibro - PAHC CFD

    11.19
    13.72%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Phibro Animal Health Corp ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 9.84
    Open* 10.05
    1-Year Change* -19.02%
    Day's Range* 10.05 - 11.2
    52 wk Range 9.40-16.52
    Average Volume (10 days) 213.17K
    Average Volume (3 months) 2.97M
    Market Cap 414.76M
    P/E Ratio 20.00
    Shares Outstanding 40.50M
    Revenue 976.72M
    EPS 0.51
    Dividend (Yield %) 4.6875
    Beta 0.65
    Next Earnings Date Feb 6, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 9.84 0.39 4.13% 9.45 9.98 9.45
    Nov 30, 2023 9.56 -0.02 -0.21% 9.58 9.81 9.47
    Nov 29, 2023 9.71 0.02 0.21% 9.69 9.99 9.63
    Nov 28, 2023 9.66 -0.43 -4.26% 10.09 10.24 9.64
    Nov 27, 2023 10.32 -0.09 -0.86% 10.41 10.47 10.23
    Nov 24, 2023 10.47 0.15 1.45% 10.32 10.56 10.29
    Nov 22, 2023 10.29 0.40 4.04% 9.89 10.32 9.89
    Nov 21, 2023 10.22 -0.19 -1.83% 10.41 10.45 10.15
    Nov 20, 2023 10.44 -0.25 -2.34% 10.69 10.90 10.31
    Nov 17, 2023 10.96 0.49 4.68% 10.47 10.97 10.47
    Nov 16, 2023 10.50 0.17 1.65% 10.33 10.55 10.20
    Nov 15, 2023 10.48 0.73 7.49% 9.75 10.56 9.73
    Nov 14, 2023 10.15 0.05 0.50% 10.10 10.40 9.84
    Nov 13, 2023 9.73 0.17 1.78% 9.56 9.86 9.38
    Nov 10, 2023 9.63 -0.05 -0.52% 9.68 9.90 9.55
    Nov 9, 2023 9.76 -0.40 -3.94% 10.16 10.74 9.73
    Nov 8, 2023 12.00 0.15 1.27% 11.85 12.15 11.85
    Nov 7, 2023 12.06 0.39 3.34% 11.67 12.30 11.67
    Nov 6, 2023 12.22 0.24 2.00% 11.98 12.34 11.98
    Nov 3, 2023 12.30 0.86 7.52% 11.44 12.37 11.44

    Phibro Events

    Time (UTC) Country Event
    Tuesday, February 6, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q2 2024 Phibro Animal Health Corp Earnings Release
    Q2 2024 Phibro Animal Health Corp Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 977.889 942.261 833.35 800.354 827.995
    Revenue 977.889 942.261 833.35 800.354 827.995
    Cost of Revenue, Total 679.652 656.861 561.973 543.472 563.371
    Gross Profit 298.237 285.4 271.377 256.882 264.624
    Total Operating Expense 906.042 863.275 758.482 731.16 744.769
    Selling/General/Admin. Expenses, Total 201.995 185.582 178.75 175.85 170.815
    Research & Development 24.395 20.832 17.759 13.738 12.083
    Unusual Expense (Income) -1.9 -1.5
    Operating Income 71.847 78.986 74.868 69.194 83.226
    Interest Income (Expense), Net Non-Operating -17.776 -6.659 -8.4 -13.682 -11.721
    Net Income Before Taxes 54.071 72.327 66.468 55.512 71.505
    Net Income After Taxes 32.606 49.175 54.385 33.552 54.353
    Net Income Before Extra. Items 32.606 49.175 54.385 33.552 54.353
    Net Income 32.606 49.175 54.385 33.552 54.713
    Income Available to Common Excl. Extra. Items 32.606 49.175 54.385 33.552 54.353
    Income Available to Common Incl. Extra. Items 32.606 49.175 54.385 33.552 54.713
    Diluted Net Income 32.606 49.175 54.385 33.552 54.713
    Diluted Weighted Average Shares 40.504 40.504 40.504 40.504 40.523
    Diluted EPS Excluding Extraordinary Items 0.80501 1.21408 1.34271 0.82836 1.34129
    Dividends per Share - Common Stock Primary Issue 0.48 0.48 0.48 0.48 0.46
    Diluted Normalized EPS 0.90764 1.22407 1.34271 0.80419 1.31715
    Other, Net 0
    Total Extraordinary Items 0.36
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 255.049 245.673 244.646 232.521 255.265
    Revenue 255.049 245.673 244.646 232.521 255.265
    Cost of Revenue, Total 178.383 170.133 167.261 163.875 176.841
    Gross Profit 76.666 75.54 77.385 68.646 78.424
    Total Operating Expense 231.283 227.12 228.802 218.837 232.379
    Selling/General/Admin. Expenses, Total 52.9 56.987 61.541 54.962 55.538
    Operating Income 23.766 18.553 15.844 13.684 22.886
    Interest Income (Expense), Net Non-Operating -2.325 -3.449 -3.735 -8.267 -10.517
    Net Income Before Taxes 21.441 15.104 12.109 5.417 12.369
    Net Income After Taxes 11.498 10.042 7.21 3.856 7.487
    Net Income Before Extra. Items 11.498 10.042 7.21 3.856 7.487
    Net Income 11.498 10.042 7.21 3.856 7.487
    Income Available to Common Excl. Extra. Items 11.498 10.042 7.21 3.856 7.487
    Income Available to Common Incl. Extra. Items 11.498 10.042 7.21 3.856 7.487
    Diluted Net Income 11.498 10.042 7.21 3.856 7.487
    Diluted Weighted Average Shares 40.504 40.504 40.504 40.504 40.504
    Diluted EPS Excluding Extraordinary Items 0.28387 0.24793 0.17801 0.0952 0.18485
    Dividends per Share - Common Stock Primary Issue 0.12 0.12 0.12 0.12 0.12
    Diluted Normalized EPS 0.28387 0.25326 0.27457 0.0952 0.1884
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total Current Assets 585.723 566.232 498.909 451.837 466.162
    Cash and Short Term Investments 81.281 91.248 93.212 91.343 81.573
    Cash & Equivalents 41.281 74.248 50.212 36.343 57.573
    Total Receivables, Net 163.479 166.537 146.852 126.522 159.022
    Accounts Receivable - Trade, Net 163.479 166.537 146.852 126.522 159.022
    Total Inventory 277.57 259.158 216.312 196.659 198.322
    Other Current Assets, Total 63.393 49.289 42.533 37.313 27.245
    Total Assets 971.397 931.699 841.325 784.1 726.671
    Property/Plant/Equipment, Total - Net 231.327 203.17 187.668 170.982 140.235
    Property/Plant/Equipment, Total - Gross 494.953 444.135 410.719 369.918 333.285
    Accumulated Depreciation, Total -263.626 -240.965 -223.051 -198.936 -193.05
    Goodwill, Net 53.274 53.226 52.679 52.679 27.348
    Intangibles, Net 54.987 63.861 62.282 70.997 47.478
    Long Term Investments 11.094 10.346 10.105 10.02 9.627
    Note Receivable - Long Term
    Other Long Term Assets, Total 34.992 34.864 29.682 27.585 35.821
    Total Current Liabilities 176 190.832 164.116 157.238 154.227
    Accounts Payable 73.853 95.596 68.362 66.091 73.189
    Accrued Expenses 41.245 47.454 48.305 38.046 36.695
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 22.295 15 9.375 18.75 12.54
    Other Current Liabilities, Total 38.607 32.782 38.074 34.351 31.803
    Total Liabilities 688.888 669.257 602.796 595.896 510.656
    Total Long Term Debt 452.541 417.925 382.71 368.257 313.635
    Long Term Debt 452.541 417.925 382.71 368.257 313.635
    Deferred Income Tax 12.146 9.264 6.646 11.68
    Other Liabilities, Total 48.201 51.236 49.324 58.721 42.794
    Total Equity 282.509 262.442 238.529 188.204 216.015
    Redeemable Preferred Stock 0 0
    Common Stock 0.004 0.004 0.004 0.004 0.004
    Additional Paid-In Capital 135.803 135.803 135.803 135.525 133.266
    Retained Earnings (Accumulated Deficit) 260.912 247.748 218.015 183.06 168.926
    Other Equity, Total -114.21 -121.113 -115.293 -130.385 -86.181
    Total Liabilities & Shareholders’ Equity 971.397 931.699 841.325 784.1 726.671
    Total Common Shares Outstanding 40.5036 40.5036 40.5036 40.4536 40.4536
    Short Term Investments 40 17 43 55 24
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 584.424 585.723 585.483 581.689 570.08
    Cash and Short Term Investments 91.153 81.281 77.238 78.422 86.28
    Cash & Equivalents 43.153 41.281 37.238 68.422 76.28
    Short Term Investments 48 40 40 10 10
    Total Receivables, Net 149.228 163.479 152.74 151.83 142.728
    Accounts Receivable - Trade, Net 149.228 163.479 152.74 151.83 142.728
    Total Inventory 279.154 277.57 292.833 288.984 280.842
    Other Current Assets, Total 64.889 63.393 62.672 62.453 60.23
    Total Assets 964.523 971.397 965.432 961.833 948.378
    Property/Plant/Equipment, Total - Net 229.679 231.327 225.391 221.881 215.652
    Goodwill, Net 53.251 53.274 53.243 53.228 53.209
    Intangibles, Net 52.184 54.987 56.901 59.064 61.133
    Long Term Investments 11.91 11.094 11.55 11.129 10.592
    Other Long Term Assets, Total 33.075 34.992 32.864 34.842 37.712
    Total Current Liabilities 172.355 176 165.308 167.569 172.499
    Accounts Payable 77.216 73.853 75.768 80.487 88.379
    Accrued Expenses 36.541 41.245 39.477 38.461 38.448
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 24.15 22.295 15.42 15.42 15.42
    Other Current Liabilities, Total 34.448 38.607 34.643 33.201 30.252
    Total Liabilities 691.454 688.888 693.104 693.463 685.622
    Total Long Term Debt 458.717 452.541 466.016 460.806 451.738
    Long Term Debt 458.717 452.541 466.016 460.806 451.738
    Deferred Income Tax 12.823 12.146 12.149 12.386 11.584
    Other Liabilities, Total 47.559 48.201 49.631 52.702 49.801
    Total Equity 273.069 282.509 272.328 268.37 262.756
    Common Stock 0.004 0.004 0.004 0.004 0.004
    Additional Paid-In Capital 135.884 135.803 135.803 135.803 135.803
    Retained Earnings (Accumulated Deficit) 248.037 260.912 254.275 249.094 246.744
    Other Equity, Total -110.856 -114.21 -117.754 -116.531 -119.795
    Total Liabilities & Shareholders’ Equity 964.523 971.397 965.432 961.833 948.378
    Total Common Shares Outstanding 40.5036 40.5036 40.5036 40.5036 40.5036
    Redeemable Preferred Stock 0 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 49.175 54.385 33.552 54.713 64.883
    Cash From Operating Activities 31.649 48.306 59.348 47.169 70.008
    Cash From Operating Activities 32.705 31.885 32.341 27.564 26.943
    Deferred Taxes -0.806 -2.183 8.125 -0.105 6.389
    Non-Cash Items -4.786 -5.912 -1.014 0.94 5.671
    Cash Taxes Paid 17.854 19.395 20.866 16.215 15.191
    Cash Interest Paid 11.159 10.808 11.577 12.25 11.208
    Changes in Working Capital -44.639 -29.869 -13.656 -35.943 -33.878
    Cash From Investing Activities -22.582 -18.58 -120.39 -14.133 -84.612
    Capital Expenditures -37.044 -29.32 -34.045 -29.891 -18.548
    Other Investing Cash Flow Items, Total 14.462 10.74 -86.345 15.758 -66.064
    Cash From Financing Activities 16.343 -16.995 40.936 -4.107 -11.775
    Financing Cash Flow Items -4.84 -2.94 0
    Total Cash Dividends Paid -19.442 -19.43 -19.418 -18.592 -16.073
    Issuance (Retirement) of Stock, Net 1.134 5.699
    Issuance (Retirement) of Debt, Net 40.625 5.375 60.354 13.351 -1.401
    Foreign Exchange Effects -1.374 1.138 -1.124 -0.524 -0.536
    Net Change in Cash 24.036 13.869 -21.23 28.405 -26.915
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 21.108 11.066 3.856 49.175 41.688
    Cash From Operating Activities -6.928 -13.187 -10.698 31.649 30.075
    Cash From Operating Activities 25.438 16.949 8.45 32.705 24.3
    Deferred Taxes 0.235 -0.121 -0.013 -0.806 -0.12
    Non-Cash Items -5.711 -1.251 3.208 -4.786 -13.891
    Cash Taxes Paid 16.163 9.319 3.802 17.854 13.432
    Cash Interest Paid 10.289 6.606 2.906 11.159 8.22
    Changes in Working Capital -47.998 -39.83 -26.199 -44.639 -21.902
    Cash From Investing Activities -63.736 -25.959 -16.149 -22.582 -13.042
    Capital Expenditures -40.903 -32.995 -23.176 -37.044 -25.154
    Other Investing Cash Flow Items, Total -22.833 7.036 7.027 14.462 12.112
    Cash From Financing Activities 33.319 33.035 29.319 16.343 3.954
    Total Cash Dividends Paid -14.581 -9.72 -4.86 -19.442 -14.581
    Issuance (Retirement) of Debt, Net 48.54 43.395 34.25 40.625 23.375
    Foreign Exchange Effects 0.335 0.285 -0.44 -1.374 -0.451
    Net Change in Cash -37.01 -5.826 2.032 24.036 20.536
    Financing Cash Flow Items -0.64 -0.64 -0.071 -4.84 -4.84
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 15.7856 3210398 51764 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 11.0299 2243215 -17118 2023-06-30 LOW
    Pzena Investment Management, LLC Investment Advisor/Hedge Fund 10.1809 2070549 -94651 2023-06-30 LOW
    Brandes Investment Partners, L.P. Investment Advisor 6.6508 1352603 72304 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.5534 926055 -9448 2023-06-30 LOW
    Heartland Advisors, Inc. Investment Advisor/Hedge Fund 3.5928 730689 790 2023-06-30
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 3.3321 677660 70673 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 2.5839 525500 1500 2023-06-30 HIGH
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 2.4676 501858 -78161 2023-06-30 MED
    Smith, Graham & Co. Investment Advisors, L.P. Investment Advisor 2.2363 454804 -19736 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0173 410267 21236 2023-06-30 LOW
    Hotchkis and Wiley Capital Management, LLC Investment Advisor 1.9446 395480 36740 2023-06-30 LOW
    Mellon Investments Corporation Investment Advisor/Hedge Fund 1.5329 311757 -710 2023-09-30 LOW
    Nuveen LLC Pension Fund 1.527 310562 -105046 2023-06-30 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.4055 285837 35735 2023-06-30 LOW
    Invesco Capital Management LLC Investment Advisor 1.2687 258017 -16122 2023-06-30 LOW
    Parametric Portfolio Associates LLC Investment Advisor 1.25 254223 27390 2023-06-30 LOW
    AQR Capital Management, LLC Investment Advisor/Hedge Fund 1.185 241001 -60237 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 1.1557 235035 -61380 2023-06-30 LOW
    Brandywine Global Investment Management, LLC Investment Advisor 1.0439 212300 212300 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Phibro Company profile

    About Phibro Animal Health Corp

    Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

    Financial summary

    BRIEF: For the six months ended 31 December 2021, Phibro Animal Health Corp revenues increased 11% to $447.4M. Net income decreased 4% to $24M. Revenues reflect Animal Health segment increase of 10% to $291.9M, Mineral Nutrition segment increase of 15% to $121.1M, United States segment increase of 10% to $265.5M, Latin America and Canada segment increase of 16% to $90.7M. Net income was offset by Selling.

    Equity composition

    Common Stock $.10 Par, 5/06, 30,300 auth., Class A 12,600 issd. Class B 11,888.50. issd. Series A Preferred Stock $100 Par, 9/05, 5,207 auth., 5,207 issd.

    Industry: Veterinary Drugs

    Glenpointe Centre East, 3Rd Floor
    300 Frank W. Burr Blvd., Suite 21
    TEANECK
    NEW JERSEY 07666
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    15,804.70 Price
    -1.170% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    41,777.50 Price
    +4.930% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.63 Price
    +0.090% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    73.29 Price
    -1.420% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee -0.0019%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading